Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.
Gastroenterol Hepatol (N Y). 2009 Jun;5(6):435-42.
Gastroenterol Hepatol (N Y). 2009.
PMID: 20574504
Free PMC article.